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Clinical Case Report
ABSTRACT
The Numb Chin Syndrome (NCS) is defined as facial and oral numbness restricted to the mental nerve’s distribution involving 
the lower lip, skin of the chin, or gingiva of the lower anterior teeth. Hypoesthesia can occur unilaterally or bilaterally. Although 
this syndrome is rare, its importance is related to the fact that it represents the clinical manifestations of malignant diseases. 
Breast cancer and non-Hodgkin lymphoma are the most common cause of NCS. The patient, a 58-year-old woman, treated 
for a Burkitt Lymphoma (BL) nine years ago, described a two-week history of change in sensitivity and pain in the chin region, 
without relief with the use of analgesics. She had no headache, speech disturbance, dysphagia, visual disturbance, or other 
neurological symptoms. No surgical intervention has been performed recently. The intraoral examination revealed a healthy 
oral mucosa and a small area adjacent to the right mental nerve region that was uncomfortable to palpation. No changes 
were found in the bone trabeculae at cone-beam computed tomography. The contrasted magnetic resonance features 
made it possible to identify a change in the mandibular body extending to the entire right side, coinciding with the patient’s 
complaint, indicating a probable mandibular medullary invasion. The patient was submitted to a biopsy to rule out a possible 
recurrence of BL. The microscopic findings were consistent with the diagnosis of BL. The present report described a very 
unusual presentation of late recurrent BL nine years after the first treatment, which manifested as an NCS. 
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INTRODUCTION
The Numb Chin Syndrome (NCS), also called 
mental nerve neuropathy, is defined as facial and oral 
numbness restricted to the mental nerve’s distribution 
involving the lower lip, skin of the chin, or gingiva 
of the lower anterior teeth. It causes a sensory 
neuropathy-like unilateral, or bilateral hypoesthesia, 
paresthesia or anesthesia in the area supplied by the 
trigeminal nerve’s mental branch. These symptoms 
reflect the anatomical substrate of this syndrome.1,2
Despite being a rare clinical manifestation, 
the importance of this syndrome lies in its frequent 
association with malignancies.3 The most common non-
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hematologic neoplastic cause of NCS is breast cancer, 
while the most common hematologic neoplastic cause 
is non-Hodgkin lymphoma (NHL).1
Lymphomas are malignant tumors derived from 
the lymphoreticular or immune system. BL belongs to 
the NHL group and is characterized by a very high and 
diffuse proliferation of B lymphocytes.2,4
Charles Bell first described NCS in 1988. This 
syndrome may be the first symptom of diseases arising 
from different etiologies, including traumatic, vascular, 
inflammatory, demyelinating, infectious, and neoplastic 
disorders.5 Therefore, the presence of NCS conditions is 
suspected often enough to warrant a search for these 
possible etiologies, because, in patients with a history 
of cancer, NCS often indicates disease recurrence or 
progression with a poor prognosis.2
In the present paper, we present a rare case of late 
recurrence of BL initially presenting with bilateral NCS.
CASE REPORT
The patient, a 58-year-old woman, treated for a BL 
nine years ago, described a two-week history of change 
in sensitivity and pain in the chin region, which did not 
relief with the use of analgesics. She had no headache, 
speech disturbance, dysphagia, visual disturbance, or 
other neurological symptoms.
At first, she looked for her hematologist-oncologist 
because of her past medical history of BL. Physical 
examination revealed complete paresthesia involving 
the chin and lower lip bilaterally, without any trauma 
and no evident increase in volume or swelling, only the 
numbness in the mental region. There was no clinical 
evidence of palpable regional lymph nodes, and all 
other systems were found to be clinically normal.
The patient was referred to the Oral Medicine 
Department, and the intraoral examination revealed 
a healthy oral mucosa, no recent tooth extraction, no 
trauma, and no oral surgery (Figure 1).
As a result of the patient’s complaint, we identified 
a small area adjacent to the region of the right mental 
nerve that was uncomfortable on palpation. No other 
changes were found by means of cone-beam computed 
tomography (Figure 2A) and clinical examination. 
Magnetic resonance features made possible to 
identify a change in the mandibular body extending 
Figure 1. Intraoral examination revealed a healthy oral 
mucosa.
Figure 2. A – Computed tomography of the mandible (axial plane) - note a reduction of bone trabeculations in 
the mandibular body, possibly related to infiltration; B and C – Axial plane of MRI with bilateral mandibular bone 
marrow signal alteration (arrows); B – T2 high signal tissue near the right mental foramen related to the involvement 
of the inferior alveolar nerve (arrow); C – Confirmation of the image in T1-weighted sequence.
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Figure 3. A – Left and B – right sagittal section of MRI (T1 weighed images). In both images, asymmetry of the 
mandibular canals is observed, with more evidence on the right side
Figure 4. Intraosseous medullar biopsy of the mandible.
to the entire right side (Figures 2B, 2C, 3A, and 3B), 
coinciding with the clinical complaint, indicating a 
probable mandibular medullary invasion.
At this time, considering the medical history, an 
intraosseous biopsy (Figure 4) adjacent to the right 
mental nerve was performed to pursue a possible 
recurrence of BL.
The microscopic analysis of the bone biopsy 
demonstrated a diffuse proliferation of moderate-
sized neoplastic cells, exhibiting hyperchromatic 
nucleoli, and scant cytoplasm. A focal starry-sky 
pattern was observed. The immunohistochemical 
profile (Figure 4) revealed positivity for BCL-6, CD-10, 
CD-20, C-MYC, PAX-5, and strong positivity for 
Ki-67, demonstrating the presence of a mature B-cell 
lineage, consistent with the diagnosis of BL (Figure 5). 
The in-situ hybridization was negative for Epstein-Barr 
virus. Rescue chemotherapy treatment was initiated 
to enable an autologous transplant to be performed.
DISCUSSION
Lymphoma is a heterogeneous malignant 
disease of the lymphatic system, characterized by a 
proliferation of lymphoid cells or their precursors. 
Lymphomas represent the third most common 
malignancy affecting the oral cavity and jawbones after 
squamous cell carcinoma and the malignant tumor of 
the salivary glands.4 They can be divided into two large 
groups: Hodgkin’s lymphoma (HL) and non-Hodgkin’s 
Lymphoma (NHL).6,7
Short et al.8 identified 145 adults with BL with a 
median age of 51 years (18-76 years). They defined a 
cut-off point: early and late relapses were defined as 
relapse <6 months and ≥6 months from the time of the 
first remission. In our case, we present an extremely 
rare and late case. Twelve patients died before initial 
response assessment, and 2 were unevaluable due to 
inadequate records, which demonstrated the severity 
of the disease. Among the 131 patients evaluable for 
response, 35 patients (27%) had relapsed (n=32) or 
were refractory (n=3). Ten patients experienced late 
relapse after the first remission and had a median 
overall survival of 5.0 months.
The first report of mental neuropathy associated 
with malignancies was filed in 1963 with the description 
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of 5 cases of patients with metastatic malignant 
disease, who had NCS as the initial presentation.1,9 
The NCS received this term because it is a sensory 
neuropathy characterized by hypoesthesia, paresthesia 
or anesthesia of the area innervated by the mental 
nerve and its branches.2 This nerve has no motor fibers, 
and NCS is a purely sensory neuropathy.3 Furthermore, 
this can result from mechanical nerve compression 
caused by osseous involvement of the mandible or 
nerve damage caused by tumor infiltration along the 
nerve sheath.1
This syndrome has been attributed to benign and 
malignant conditions,2 including lymphoma, acute 
leukemia, BL, multiple myeloma, Ewing sarcoma, 
melanoma, breast cancer, prostate cancer, lung 
cancer, colon cancer, and esophageal cancer.1 In 
a retrospective case series of NCS, the incidence 
indicated a significant difference between patients 
with metastatic cancer (23%, 12 of 53) and those 
with benign diseases (4%, 4 of 104), showing the 
importance of NCS as a neurological manifestation in 
cases of cancer and/or metastatic malignancy.5
Some cases of NCS may also be the first sign of 
recurrence or metastasis in patients with a history of 
malignancy, or sometimes the first manifestation in 
hematologic malignancies.2 Sasaki et al.1 reviewed 
some cases, and the onset of bilateral NCS preceded 
the diagnosis of the primary tumor in 8 out of the 
22 cases. Lu et al.5 described a total of 12 patients 
who complained about oral symptoms that led to the 
diagnoses of NCS associated with metastatic cancer. 
Although they are not specific symptoms, dentists 
and physicians need to take special heed of these 
symptoms.
This syndrome requires special attention from 
clinicians in BL cases to avoid misdiagnosis since there 
are other causes of NCS. A review of literature1,2,10 
showed some other etiologies of NCS, including 
dental or odontogenic processes such as (i) trauma, (ii) 
infection, (iii) locally invasive tumors, (iv) mandibular 
osteomyelitis; (v) metastatic neoplasms; (vi) multiple 
myeloma; (vii) sickle cell disease; (viii) multiple 
sclerosis; (ix) sarcoidosis; (x) Lyme disease; (xi) temporal 
arteritis; (xii) diabetic neuropathy; (xii) AIDS; and (xiv) 
medication-related osteonecrosis of the jaw (MRONJ).
Fortunato et al.3 conducted a study from 2010 to 
2016 recruiting patients who presented NCS as one of 
their symptoms, excluding those in whom it depended 
on a clear odontogenic cause, systemic degenerative 
diseases or metabolic disorders. As the first symptom, 
Figure 5.  Immunohistochemical profile, revealed positivity for BCL-6, CD-10, CD-20, C-MYC, PAX-5 and strong 
positivity for Ki-67. 
Benites BM, Miranda-Silva W, Rocha AC, et al.
5-6Autops Case Rep (São Paulo). 2021;  11: e2020218
116 patients presented NCS, but only 29 were included 
in the study. The family dentist was the first to observe 
the symptom in the great majority of cases (62%); 
only 6 patients were referred by an oncologist. In all 
cases, NCS was unilateral; in 11 cases, it was the first 
symptom of malignancy; and in only 2 cases (6.8%) 
the patients had non-Hodgkin Lymphoma.
On the other hand, Sasaki et al.,1 conducted a 
review of bilateral numbness of the lower lip and chin 
and found 22 cases of bilateral NCS associated with 
malignancy. The primary disease was BL in 5 cases. 
Interestingly, as previously reported, the onset of 
bilateral NCS preceded the diagnosis of the primary 
tumor in 8 out of the 22 cases. In the remaining 
14 cases, the onset of NCS was associated with 
progression, recurrence, or metastasis of the primary 
tumor, in a manner similar to that of our case. The 
above-mentioned review detected more cases of 
bilateral NCS associated with hematologic malignancies 
than with solid malignancies. Algahtani et al.,2 in their 
review, believed that this could be explained by the 
fact that hematologic malignancies infiltrated into the 
central nervous system more readily than did the solid 
neoplasms.
In clinical practice, most clinicians do not request 
panoramic radiography of the jaw to start the 
investigation. In general, physicians do not start 
with either computed tomography (CT) or magnetic 
resonance image (MRI) of the jaw, face, and brain, 
which fails to place value on the patient’s chief 
complaint. CT imaging of the brain and base of the 
skull makes it possible to identify lytic lesions involving 
the inferior alveolar nerve or the mental foramen. Some 
authors have recommended MRI scanning of the face 
if the etiology of the mental neuropathy is unclear 
after routine imaging studies have been performed.2
According to the characteristics of each case, 
there were some possible diagnostic hypotheses 
to be considered, such as Fortunato et al.3 in their 
patients: osteomyelitis, MRONJ, odontogenic tumor, 
odontogenic cysts, because local dental causes are 
most often responsible for NCS. Although there are 
few case reports in the literature1,2,4,10 all studies were 
in agreement in saying that NCS may be the first sign 
of recurrence or disease progression in patients with 
a history of cancer.
In conclusion, the present report described a very 
unusual presentation of late recurrent BL nine years 
after the first treatment, which manifested as an NCS.
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